Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Murray S, Timotheadou E, Linardou H, Vrettou AV, Kostopoulos I, Skrickova J, Papakostantinou C, Christodoulou C, Pectasides D, Samantas E, Papakostas P, Skarlos DV, Kosmidis P, Fountzilas G. Murray S, et al. Among authors: kosmidis p. Lung Cancer. 2006 May;52(2):225-33. doi: 10.1016/j.lungcan.2005.12.015. Epub 2006 Mar 29. Lung Cancer. 2006. PMID: 16567021
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
Skarlos DV, Dimopoulos AM, Kosmidis P, Papakostas P, Pavlidis N, Bacoyiannis C, Kiamouris C, Klouvas G, Gogas H, Fountzilas G, Samantas E; Hellenic Cooperative Oncology Group. Skarlos DV, et al. Among authors: kosmidis p. Lung Cancer. 2003 Jul;41(1):107-11. doi: 10.1016/s0169-5002(03)00154-5. Lung Cancer. 2003. PMID: 12826319 Clinical Trial.
Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
Timotheadou E, Skarlos DV, Samantas E, Papadopoulos S, Murray S, Skrickova J, Christodoulou C, Papakostantinou C, Pectasides D, Papakostas P, Kaplanova J, Vrettou E, Karina M, Kosmidis P, Fountzilas G. Timotheadou E, et al. Among authors: kosmidis p. Anticancer Res. 2007 Nov-Dec;27(6C):4481-9. Anticancer Res. 2007. PMID: 18214064 Free article.
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.
Pectasides D, Samantas E, Fountzilas G, Briasoulis E, Kosmidis P, Skarlos D, Dimopoulos MA, Kalofonos HP, Economopoulos T, Syrigos K. Pectasides D, et al. Among authors: kosmidis p. Lung Cancer. 2007 Dec;58(3):355-61. doi: 10.1016/j.lungcan.2007.06.027. Epub 2007 Aug 15. Lung Cancer. 2007. PMID: 17698241 Clinical Trial.
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Kosmidis PA, Kalofonos HP, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, Bakogiannis C, Nicolaides C, Bafaloukos D, Bamias A, Samantas E, Xiros N, Boukovinas I, Fountzilas G, Dimopoulos MA. Kosmidis PA, et al. Ann Oncol. 2008 Jan;19(1):115-22. doi: 10.1093/annonc/mdm430. Epub 2007 Oct 15. Ann Oncol. 2008. PMID: 17938425 Free article. Clinical Trial.
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Kosmidis PA, Fountzilas G, Eleftheraki AG, Kalofonos HP, Pentheroudakis G, Skarlos D, Dimopoulos MA, Bafaloukos D, Pectasides D, Samantas E, Boukovinas J, Lambaki S, Katirtzoglou N, Bakogiannis C, Syrigos KN. Kosmidis PA, et al. Ann Oncol. 2011 Apr;22(4):827-834. doi: 10.1093/annonc/mdq445. Epub 2010 Sep 29. Ann Oncol. 2011. PMID: 20880999 Free article. Clinical Trial.
264 results